Lensar (LNSR) Share-based Compensation Growth (1y) (2020 - 2026)
Lensar (LNSR) Share-based Compensation Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn | 18.31% |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn | -78.13% |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn | 6.74% |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn | 16.00% |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 12.53% |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn | -13.91% |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn | 60.71% |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn | 5.29% |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn | 7.56% |
| 10 | Lensar | 101.57 Mn | 88.01 Mn | 9.78 Mn | -54.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -54.70% |
| Mar 31, 2026 | 5.50% |
| Dec 31, 2025 | 31.87% |
| Sep 30, 2025 | 27.25% |
| Jun 30, 2025 | 12.15% |
| Mar 31, 2025 | 0.31% |
| Dec 31, 2024 | 141.90% |
| Sep 30, 2024 | -43.05% |
| Jun 30, 2024 | -62.55% |
| Mar 31, 2024 | -62.22% |
| Dec 31, 2023 | -193.22% |
| Sep 30, 2023 | -29.84% |
| Jun 30, 2023 | 11.42% |
| Mar 31, 2023 | 7.41% |
| Dec 31, 2022 | 9.85% |
| Sep 30, 2022 | 6.29% |
| Jun 30, 2022 | 14.48% |
| Mar 31, 2022 | -30.73% |
| Dec 31, 2021 | 149.34% |
| Sep 30, 2021 | -58.04% |